期刊文献+

去氨加压素联合血小板在抗凝及抗血小板相关性脑出血围术期止血效果 被引量:1

Hemostatic Effect of Desmopressin Combined with Platelet in Perioperative Period of Anticoagulation and Antiplatelet-related Cerebral Hemorrhage
下载PDF
导出
摘要 目的:探讨去氨加压素联合血小板在抗凝及抗血小板相关性脑出血围术期止血效果。方法:将2017年1月-2019年1月笔者所在医院收治的200例抗凝及抗血小板相关性脑出血患者分为观察组和对照组,各100例。对照组仅采用血小板输注治疗,观察组在对照组基础上加用去氨加压素。通过观察两组PT、APTT、INR、术中出血量、术后引流量及再出血量等情况,评价去氨加压素联合血小板在抗凝及抗血小板相关性脑出血围术期止血效果。结果:两组治疗后PT、APTT、INR均低于治疗前,且观察组明显低于对照组,差异均有统计学意义(P<0.05)。对照组术中出血量、术后引流量及再出血量均明显多于观察组,差异均有统计学意义(P<0.05)。结论:去氨加压素联合血小板可改善抗凝及抗血小板相关性脑出血患者凝血功能障碍,降低围术期出血风险,从而提高手术成功率,值得临床推广应用。 Objective:To investigate the hemostatic effect of Desmopressin combined with platelet in anticoagulation and antiplatelet-related cerebral hemorrhage during perioperative period.Method:A total of 200 patients with anticoagulation and antiplatelet-related cerebral hemorrhage admitted to our hospital from January 2017 to January 2019 were divided into the observation group and the control group,100 cases in each group.The control group was treated only with platelet transfusion,while the observation group was treated with Desmopressin on the basis of the control group.By observing the conditions of PT,APTT,INR,intraoperative bleeding volume,postoperative drainage volume and rebleeding volume of the two groups,the hemostatic effect of Desmopressin combined with platelet in anticoagulation and antiplatelet-related cerebral hemorrhage during perioperative period was evaluated.Result:PT,APTT and INR of the two groups after treatment were lower than those before treatment,and the observation group were significantly lower than those of the control group,and the differences were statistically significant(P<0.05).Intraoperative bleeding volume,postoperative drainage volume and rebleeding volume in the control group were significantly more than those of the observation group,and the differences were statistically significant(P<0.05).Conclusion:Desmopressin combined with platelets can improve coagulation dysfunction in patients with anticoagulation and antiplatelet related intracerebral hemorrhage,reduce the risk of perioperative bleeding,thereby improving the success rate of surgery,and is worthy of clinical application.
作者 胡正祥 柯学庭 尹东旭 陈茵茵 HU Zhengxiang;KE Xueting;YIN Dongxu;CHEN Yinyin(People’s Hospital of Zhongkai High-tech Zone,Huizhou City,Huizhou 516229,China)
出处 《中外医学研究》 2019年第29期16-17,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 2018年惠州市科技计划(医疗卫生)项目(项目编号:2018Y243)
关键词 去氨加压素 血小板 抗凝 抗血小板 脑出血 围术期 止血效果 Desmopressin Platelet Anticoagulation Antiplatelet Cerebral hemorrhage Perioperative period Hemostatic effect
  • 相关文献

参考文献10

二级参考文献77

  • 1李建生,余学庆,胡金亮,程龙.中医证候标准建立的思路与方法[J].河南中医学院学报,2004(6):4-6. 被引量:96
  • 2何清,吕蓉.老年痴呆早期康复护理训练[J].泸州医学院学报,2004,27(6):558-558. 被引量:7
  • 3Corren J,Casale TB,Lanier B,et al.Safety and tolerability of omalizumab[J].Clin Exp Allergy,2009,39(6):788-797.
  • 4Wenzel SE,Barnes PJ,Bleecker ER,et al.Asthma investigators:a randomized,double-blind,placebo-controlled study of tumor necrosis factor-{alpha}blockade in severe persistent asthma[J].Am J Respir Crit Care M ed,2009,179(7):549-558.
  • 5Nair P,Pizzichini MM,Kjarsgaard M,et al.Mepolizumab for prednisone-dependent asthma with sputum eosinophilia[J].N Engl J M ed,2009,360(10):985-993.
  • 6Haldar P,Brightling CE,Hargadon B,et al.Mepolizumab and exacerbations of refractory eosinophilic asthma[J].N Engl J M ed,2009,360(10):973-984.
  • 7Gauvreau GM,Boulet L-P,Cockcroft DW,et al.The effects of IL-13 blockade on allergen-induced airw ay responses in mild atopic asthma[J].Am J Respir Crit Care M ed,2011,183(8):1007-1014.
  • 8Busse WW,Israel E,Nelson HS,et al.Daclizumab improves asthma control in patients with moderate to severe persistent asthma:a randomized,controlled trial[J].Am J Respir Crit Care M ed,2008,178(10):1002-1008.
  • 9Zhang J,Cavet M,Vander Meid K,et al.BOL-303242-X,a novel selective glucocorticoid receptor agonist,w ith full antiinflammatory properties in human ocular cells[J].M ol Vis,2009,15:2606-2616.
  • 10Sch?cke H,Zollner TM,D?cke WD,et al.Characterization of ZK 245186,a novel,selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases[J].Br J Pharmacol,2009,158(4):1088-1103.

共引文献317

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部